info icon

This is a non-core endpoint: only basic statistics are computed.

Other specified disorders of eye and adnexa in diseases classified elsewhere

H7_OTHEREYEINOTH

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

11

4. Check minimum number of events

None

11

5. Include endpoints

None

11

6. Filter based on genotype QC (FinnGen only)

11

Control definitions (FinnGen only)

Control exclude
H7_EYEOTH

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 48 30 18
Only index persons 45 30 15
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population - 55.59 51.26
Only index persons 54.61 55.59 52.65

-FinnGen-

Key figures

All Female Male
Number of individuals 11 6 5
Unadjusted period prevalence (%) 0.00 0.00 0.00
Median age at first event (years) 54.29 46.06 64.15

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
6
17
6.42
2.21
7.5
5.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
6
33
2.77
0.76
8.5
5.0
%
1.0
0.8
—
6
33
(3006504) Eosinophils/100 leukocytes in Blood
6
34
2.66
0.76
8.7
4.9
%
3.3
2.8
—
6
34
(3019069) Monocytes/100 leukocytes in Blood
6
36
2.45
0.73
8.8
4.7
%
9.3
9.0
—
6
36
(3018010) Neutrophils/100 leukocytes in Blood
6
37
2.35
0.71
8.7
4.5
%
59.3
54.9
—
6
37
(3015736) pH of Urine
5
29
2.31
0.54
2.4
3.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
0
15
0.00
0.45
0.0
3.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
0
17
0.00
0.44
0.0
1.2
—
4.1
—
0
9
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5
36
1.70
0.30
4.0
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
5
40
1.45
0.27
2.6
3.5
—
0.0
—
0
9
(3022145) Colonoscopy Study observation
0
11
0.00
0.22
0.0
1.3
—
—
—
0
0
(4035726)
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
12
0.00
0.22
0.0
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
0
12
0.00
0.22
0.0
1.5
—
29.1
—
0
12
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
0
13
0.00
0.22
0.0
3.3
—
1.3
—
0
13
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
13
0.00
0.22
0.0
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
5
42
1.35
0.13
2.6
3.5
—
0.0
—
0
9
(3021601) Nitrite [Presence] in Urine by Test strip
5
42
1.35
0.13
4.2
4.5
—
0.0
—
0
8
(3012544) pH of Venous blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
0
5
0.00
0.00
0.0
1.6
—
2.0
—
0
5
(3049717) Cytology report of Urine Cyto stain
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.6
—
13.1
—
0
5
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
0
5
0.00
0.00
0.0
1.6
—
0.6
—
0
5
(3003458) Phosphate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.8
—
1.1
—
0
9
(3014111) Lactate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
0.8
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.7
—
68.7
—
0
6
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5
53
0.90
0.00
2.6
3.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4010399)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
0.8
—
0
6
(3037467) Urinalysis macro (dipstick) panel - Urine
6
63
0.90
0.00
6.7
3.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
39.3
—
0
6
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
0
6
0.00
0.00
0.0
3.5
—
4.6
—
0
6
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
0
7
0.00
0.00
0.0
2.4
—
124.9
—
0
7
(3019060) Gas panel - Arterial blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.7
—
9.9
—
0
7
(3016502) Oxygen saturation in Arterial blood
0
8
0.00
0.00
0.0
2.9
—
96.1
—
0
8
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
7
0.00
0.00
0.0
2.1
—
0.0
—
0
7
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.7
—
155.5
—
0
6
(3027801) Oxygen [Partial pressure] in Arterial blood
0
8
0.00
0.00
0.0
2.8
—
11.3
—
0
8
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
2.8
—
0
7
(3008152) Bicarbonate [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
4.3
—
23.3
—
0
6
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
6
0.00
0.00
0.0
3.5
—
5.0
—
0
6
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
0
8
0.00
0.00
0.0
2.8
—
4.6
—
0
8

Mortality – FinRegistry

Association

Association between endpoint H7_OTHEREYEINOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H7_OTHEREYEINOTH.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: H7_OTHEREYEINOTH – Other specified disorders of eye and adnexa in diseases classified elsewhere

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data